C A Cull

6.1k total citations · 2 hit papers
37 papers, 4.4k citations indexed

About

C A Cull is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Pharmacology. According to data from OpenAlex, C A Cull has authored 37 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Genetics and 6 papers in Pharmacology. Recurrent topics in C A Cull's work include Diabetes Treatment and Management (13 papers), Diabetes Management and Research (12 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). C A Cull is often cited by papers focused on Diabetes Treatment and Management (13 papers), Diabetes Management and Research (12 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). C A Cull collaborates with scholars based in United Kingdom, Australia and Italy. C A Cull's co-authors include Rury R. Holman, Amanda Adler, Susan E. Manley, Richard Stevens, Rudy Bilous, Ravi Retnakaran, Kerensa Thorne, Alex Wright, Irene Stratton and Richard Paisey and has published in prestigious journals such as Circulation, Diabetes Care and Diabetes.

In The Last Decade

C A Cull

37 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)

2003 1.3k citations Amanda Adler, Richard Stevens et al. Kidney International profile →
Risk Factors for Renal Dysfunction in Type 2 Diabetes

2006 731 citations C A Cull, Amanda Adler et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C A Cull United Kingdom	24	2.9k	1.3k	755	680	633	37	4.4k
Roberto Trevisan Italy	38	2.7k 0.9×	1.8k 1.4×	1.3k 1.7×	880 1.3×	771 1.2×	126	5.3k
Markku Saraheimo Finland	33	1.8k 0.6×	905 0.7×	794 1.1×	594 0.9×	341 0.5×	63	3.6k
Lena M. Thorn Finland	33	1.7k 0.6×	954 0.7×	823 1.1×	498 0.7×	412 0.7×	87	3.6k
Susan E. Manley United Kingdom	21	3.5k 1.2×	915 0.7×	1.1k 1.4×	1.6k 2.3×	773 1.2×	51	5.8k
Rudy Bilous United Kingdom	24	1.9k 0.7×	1.4k 1.1×	959 1.3×	500 0.7×	420 0.7×	51	4.2k
Sally M. Marshall United Kingdom	33	1.4k 0.5×	975 0.8×	841 1.1×	637 0.9×	532 0.8×	93	3.3k
Giuseppe Penno Italy	40	1.8k 0.6×	1.3k 1.0×	1.4k 1.8×	605 0.9×	671 1.1×	150	4.6k
Peter Hovind Denmark	37	1.4k 0.5×	1.7k 1.3×	1.0k 1.4×	573 0.8×	579 0.9×	72	4.2k
Stuart Warren United States	15	3.3k 1.2×	684 0.5×	1.4k 1.9×	812 1.2×	944 1.5×	22	5.6k
Johan Wadén Finland	32	1.7k 0.6×	794 0.6×	780 1.0×	475 0.7×	285 0.5×	50	3.2k

Countries citing papers authored by C A Cull

Since Specialization

Citations

This map shows the geographic impact of C A Cull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C A Cull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C A Cull more than expected).

Fields of papers citing papers by C A Cull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C A Cull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C A Cull. The network helps show where C A Cull may publish in the future.

Co-authorship network of co-authors of C A Cull

This figure shows the co-authorship network connecting the top 25 collaborators of C A Cull. A scholar is included among the top collaborators of C A Cull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C A Cull. C A Cull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stratton, Irene, C A Cull, Amanda Adler, et al.. (2006). Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 49(8). 1761–1769. 254 indexed citations

Wright, Alex, C A Cull, Kenneth M. MacLeod, & Rury R. Holman. (2006). Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73. Journal of Diabetes and its Complications. 20(6). 395–401. 115 indexed citations

Stettler, Christoph, Sabin Allemann, Peter Jüni, et al.. (2006). Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. American Heart Journal. 152(1). 27–38. 343 indexed citations

Bottazzo, G. F., Emanuele Bosi, C A Cull, et al.. (2005). IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (vol 48, pg 703, 2005). Diabetologia. 48. 1240–1240. 3 indexed citations

Thomason, Margaret J., Jane Biddulph, C A Cull, & Rury R. Holman. (2005). Reporting of diabetes on death certificates using data from the UK Prospective Diabetes Study. Diabetic Medicine. 22(8). 1031–1036. 29 indexed citations

Phillips, D. I. W., et al.. (2005). A common mitchondrial DNA variant is associated with thinness in mothers and their 20-yr-old offspring. American Journal of Physiology-Endocrinology and Metabolism. 289(6). E1110–E1114. 13 indexed citations

Cull, C A, H. A. W. Neil, & R. R. Holman. (2004). Changing aspirin use in patients with Type 2 diabetes in the UKPDS. Diabetic Medicine. 21(12). 1368–1371. 34 indexed citations

Williams, Alistair J.K., P. J. Bingley, J Lévy, et al.. (2004). GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requirement. Diabetologia. 47. 1 indexed citations

Burden, A C, Alex Wright, C A Cull, Richard Paisey, & Rury R. Holman. (2003). Sulfonylurea Inadequacy Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Przewodnik Lekarza/Guide for GPs. 5(11). 40–52. 30 indexed citations

10.

Adler, Amanda, Richard Stevens, Susan E. Manley, et al.. (2003). Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney International. 63(1). 225–232. 1289 indexed citations breakdown →

11.

Davis, Timothy M. E., Z Mehta, C A Cull, et al.. (2003). Autoantibodies to the islet cell antigen SOX‐13 are associated with duration but not type of diabetes. Diabetic Medicine. 20(3). 198–204. 6 indexed citations

12.

Cull, C A, et al.. (2001). Hypoglycaemia in patients with Type 2 diabetes in the UKPDS. Diabetologia. 44. 2 indexed citations

13.

Gray, Alastair, Philip Clarke, Maria Raikou, et al.. (2001). An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54). Diabetic Medicine. 18(6). 438–444. 14 indexed citations

14.

Clarke, Philip, Alastair Gray, Amanda Adler, et al.. (2001). Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51). Diabetologia. 44(3). 298–304. 74 indexed citations

15.

Hashim, Y, Dawn Shepherd, R. R. Holman, et al.. (2001). Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects. Diabetologia. 44(12). 2227–2230. 41 indexed citations

16.

Manley, Susan E., Irene Stratton, C A Cull, et al.. (2000). Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). Diabetic Medicine. 17(7). 518–523. 47 indexed citations

17.

Cull, C A, et al.. (1999). Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS. Diabetologia. 42. 1 indexed citations

18.

Holman, R R, et al.. (1995). Authors' reply. BMJ. 310(6985). 1006.1–1006.1. 2 indexed citations

19.

Lévy, J, C A Cull, Irene Stratton, R R Holman, & R. C. Turner. (1993). [The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results].. PubMed. 123–37. 2 indexed citations

20.

Cull, C A, Susan E. Manley, Valeria Frighi, Rury R. Holman, & R. C. Turner. (1993). UK PROSPECTIVE DIABETES STUDY (UKPDS) .10. URINARY ALBUMIN EXCRETION OVER 3 YEARS IN DIET-TREATED TYPE-2, (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA. Diabetologia. 36. 1021–1029. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact